Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$15,129,610
+$5,159,304 QoQ
Shares Held
12,614
+16.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.73%
of 13F equity value
Holder Rank
#1,037
of 4,621 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Community Financial Services Group, LLC holds $29,647,618 across 10 Drug Manufacturers - General names. LLY ranks #1 (51.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
12,614 | $15,129,610 | |
| 2 | ABBV |
AbbVie Inc.
|
33,749 | $8,492,598 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,385 | $3,775,972 | |
| 4 | JNJ |
Johnson & Johnson
|
5,518 | $1,401,406 | |
| 5 | PFE |
Pfizer Inc
|
15,023 | $361,753 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,931 | $111,263 | |
| 7 | NVS |
Novartis AG
|
663 | $103,905 | |
| 8 | AMGN |
Amgen Inc
|
279 | $101,031 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,129,610 | 12,614 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $9,970,306 | 10,840 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $11,500,151 | 10,701 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $8,415,127 | 11,029 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $7,581,708 | 9,726 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $7,878,355 | 9,539 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,543,212 | 9,771 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $8,071,798 | 9,111 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $8,057,881 | 8,900 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,674,169 | 2,152 | Shares | Sole | 2024-04-23 | |
| No filing history on record for this holder in this stock. | ||||||